Vyzulta is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Latanoprostene Bunod.
| Product ID | 24208-504_06204573-97d3-4253-8685-87273ea08d58 |
| NDC | 24208-504 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vyzulta |
| Generic Name | Latanoprostene Bunod |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2017-11-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA207795 |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | LATANOPROSTENE BUNOD |
| Active Ingredient Strength | 0 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-06-11 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| Marketing Category | NDA |
| Application Number | NDA207795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2017-11-02 |
| Marketing Category | NDA |
| Application Number | NDA207795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-06-11 |
| Marketing Category | NDA |
| Application Number | NDA207795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-06-11 |
| Marketing Category | NDA |
| Application Number | NDA207795 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-11-02 |
| Ingredient | Strength |
|---|---|
| LATANOPROSTENE BUNOD | .24 mg/mL |
| SPL SET ID: | 60ce7900-a677-4fc2-88d0-1603baa9dbd4 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VYZULTA 87474310 not registered Dead/Abandoned |
Bausch & Lomb Incorporated 2017-06-04 |
![]() VYZULTA 87473150 5525995 Live/Registered |
Bausch & Lomb Incorporated 2017-06-02 |
![]() VYZULTA 86111055 not registered Dead/Abandoned |
Bausch & Lomb Incorporated 2013-11-05 |